Gene therapy startup bursts forth from incubation at J&J and F-Prime, graduating with $80M and a Novartis veteran at the helm
Gene therapy startup bursts forth from incubation at J&J and [...]
Little European biotech Sotio nabs a super $316M funding round for its superagonist work
Little European biotech Sotio nabs a super $316M funding round [...]
BeyondSpring lurches down as FDA rejects plinabulin, raising questions about lung cancer prospects
BeyondSpring lurches down as FDA rejects plinabulin, raising questions about [...]
Fore fires CEO Malik after SEC insider trading charges during his time as Immunomedics CFO
Fore fires CEO Malik after SEC insider trading charges during [...]
Alpha challenger: Novartis pays UCB $150M to join Roche, AstraZeneca in Parkinson’s race
Alpha challenger: Novartis pays UCB $150M to join Roche, AstraZeneca [...]
GlaxoSmithKline, University of Oxford join forces in $40M digital deep dive into neuro
GlaxoSmithKline, University of Oxford join forces in $40M digital deep [...]
Tune Therapeutics’ epigenetic platform resonates with investors as it snags $40M in financing
Tune Therapeutics’ epigenetic platform resonates with investors as it snags [...]
Aclaris’ experimental rheumatoid arthritis drug bolsters chemo in pancreatic cancer models
Aclaris’ experimental rheumatoid arthritis drug bolsters chemo in pancreatic cancer [...]
Astellas becomes latest Dyno gene therapy partner with $1.6B biobucks pact to join Roche, Novartis, Sarepta
Astellas becomes latest Dyno gene therapy partner with $1.6B biobucks [...]
Vertex once again talks up a tiny trial with positive read-throughs, this time for a genetically driven approach to kidney disease
Vertex once again talks up a tiny trial with positive [...]